Treatment of Ulcerative Colitis with Bloody Diarrhea
For ulcerative colitis presenting with bloody diarrhea, immediately classify disease severity using Truelove and Witts' criteria to determine if the patient has mild-moderate distal disease (requiring topical plus oral mesalamine) versus severe disease (requiring immediate IV corticosteroids with joint gastroenterology-surgery management). 1
Initial Severity Assessment
The first critical step is determining disease severity, as this dictates the entire treatment pathway:
Severe UC is defined by: bloody stool frequency ≥6/day PLUS at least one of the following: heart rate >90/min, temperature >37.8°C, hemoglobin <10.5 g/dL, or ESR >30 mm/h (CRP >30 mg/L can substitute) 1
- Patients meeting these criteria require immediate hospital admission for intensive IV therapy without delay 2, 1
- Do not wait for stool culture results before initiating corticosteroid treatment, even though acute onset UC can be difficult to distinguish from infectious colitis 2, 1
Treatment Algorithm by Disease Severity
Mild to Moderate Distal UC (Proctitis or Left-Sided Disease)
First-line therapy: Combination of topical mesalamine 1g daily PLUS oral mesalamine 2-4g daily 1
- This combination is more effective than either agent alone 2
- For proctitis specifically, mesalamine 1g suppository once daily is first-line 1
- Topical corticosteroids are less effective than topical mesalamine and should be reserved as second-line for patients intolerant of topical mesalamine 2
If no improvement on combination therapy: Escalate to oral prednisolone 40mg daily with continued topical agents as adjunctive therapy 2, 1
- Taper prednisolone gradually over 8 weeks according to severity and patient response 2
Severe UC Requiring Hospitalization
Immediate management upon admission:
- Start IV hydrocortisone 100mg four times daily OR methylprednisolone 40-60mg daily immediately 1
- Establish joint care with gastroenterologist AND colorectal surgeon from admission 1
- Inform patient of 25-30% chance of needing colectomy 2, 1
Intensive monitoring protocol:
- Physical examination daily for abdominal tenderness and rebound 2
- Vital signs four times daily 2
- Stool chart documenting frequency, character, and presence of blood 2
- FBC, ESR/CRP, electrolytes, albumin, and liver function every 24-48 hours 2
- Daily abdominal radiography if colonic dilatation (transverse colon >5.5cm) detected at presentation 2
Supportive care:
- IV fluid and electrolyte replacement to correct dehydration 2
- Blood transfusion to maintain hemoglobin >10 g/dL 2
- Subcutaneous heparin to reduce thromboembolism risk 2
- Nutritional support (enteral or parenteral) if malnourished 2
Rescue Therapy for Steroid-Refractory Disease
If no response to IV corticosteroids after 3-5 days: Two equally effective rescue options exist 1
Critical timing: Limit IV corticosteroid duration to 7-10 days maximum, as extending beyond this carries no additional benefit and delays definitive therapy 1
- Overall response rate to IV corticosteroids is 67%, with 33% requiring colectomy 1
- Do not extend IV corticosteroids beyond 7-10 days without escalating to rescue therapy or surgery 1
Surgical Indications
Absolute Emergency Indications (Immediate Surgery)
- Free perforation with generalized peritonitis 1
- Life-threatening hemorrhage with hemodynamic instability despite resuscitation 1
- Toxic megacolon complicated by perforation, massive bleeding, clinical deterioration, or signs of shock 4, 1
Mandatory Surgery Within 24-48 Hours
Toxic megacolon with no clinical improvement after 24-48 hours of medical treatment requires mandatory surgery 4, 1
- Surgery should not be delayed beyond 48-72 hours from diagnosis if no clinical improvement, as prolonged observation increases perforation risk and mortality 4
- The most critical error is delaying surgery while attempting additional medical therapy in a patient who has already failed medical treatment and has toxic megacolon, which substantially increases mortality 4
Surgical procedure of choice: Subtotal colectomy with end ileostomy 4, 1
Maintenance Therapy After Remission Induction
Lifelong maintenance therapy is recommended for all patients, particularly those with left-sided or extensive disease 2, 1
- Continue with the agent successful in achieving induction, except corticosteroids 1
- For moderate-to-severe disease requiring biologics, options include infliximab, adalimumab, vedolizumab, ustekinumab, or tofacitinib 1
- Maintenance therapy reduces the risk of colorectal cancer 2
Critical Pitfalls to Avoid
- Never delay corticosteroid treatment while waiting for stool microbiology results in suspected severe UC 1
- Never delay surgery in critically ill patients with toxic megacolon, as this increases perforation risk with high mortality 1
- Never extend IV corticosteroids beyond 7-10 days without escalating to rescue therapy or surgery 1
- Never manage severe UC without early surgical consultation, as delayed surgery is associated with high morbidity 1